Immunocompromise and Special Populations

People whose immune defences are weakened by disease, medication, or transplantation form a distinct group in infectious-disease epidemiology. They acquire infection more readily, are susceptible to organisms that rarely trouble immunocompetent hosts (opportunistic infections), and often present atypically. This topic describes how immunocompromise reshapes susceptibility and the spectrum of disease, and why such hosts are treated as special populations.

Definition

An immunocompromised host is an individual whose innate or adaptive immune defences are impaired by disease, immunosuppressive therapy, or transplantation, resulting in increased susceptibility to infection, including opportunistic infections caused by organisms of low virulence in immunocompetent people.

Scope

The topic covers immunocompromise as a host state that alters infection risk and disease spectrum, including transplant recipients, people receiving immunosuppressive therapy, and others with impaired immunity. It treats these populations at conceptual and epidemiological level, including the rationale for special preventive considerations such as vaccination, but does not give individualised treatment or dosing. It is closely linked to age-related and comorbidity topics, since immunosuppression frequently co-occurs with them.

Core questions

• How does impaired immunity change the risk and spectrum of infection?
• What are opportunistic infections and why do they emerge in immunocompromised hosts?
• How does the timing and type of immunosuppression shape which infections occur?
• Why do immunocompromised people require distinct preventive considerations such as tailored vaccination?

Key concepts

• Immunocompromised host
• Opportunistic infection
• Immunosuppression
• Transplant recipients
• Net state of immunosuppression
• Atypical presentation

Key theories

Damage-response framework in the impaired host

The damage-response framework of Casadevall and Pirofski explains why outcome depends on host immune state: when defences are weak, organisms of low virulence can cause substantial damage, accounting for the prominence of opportunistic infection in immunocompromised hosts.

Mechanisms

Impairment of immune defence can affect innate barriers, neutrophil number and function, cellular (T-cell) immunity, or humoral (antibody) immunity, and each deficit predisposes to a characteristic set of pathogens. Fishman describes how, in solid-organ transplant recipients, the risk of specific infections reflects the net state of immunosuppression together with epidemiological exposures and shifts over time after transplantation. Because the host can no longer reliably contain organisms, microbes that are normally harmless or commensal may cause invasive disease; the damage-response framework frames this as the expected consequence of altered host immunity rather than of changed microbial virulence.

Clinical relevance

Immunocompromise is a recognised host factor that defines populations at elevated infection risk and shapes which pathogens are of concern, including the rationale for tailored preventive strategies such as the IDSA guidance on vaccinating the immunocompromised host. This topic is a reference for understanding that risk at population level; it summarises why these hosts differ and does not constitute individual diagnostic or treatment advice.

Epidemiology

Immunocompromised people carry a disproportionate burden of infection, including opportunistic and invasive disease, and their numbers have grown with expanding use of transplantation, cancer therapy, and immunomodulatory drugs. In solid-organ transplant recipients, infection risk follows a recognisable temporal pattern after transplantation and is a major source of morbidity, as reviewed by Fishman.

Key figures

• Jay Fishman
• Arturo Casadevall
• Liise-anne Pirofski

Seminal works

• fishman-2007
• casadevall-pirofski-2003
• rubin-2014

Frequently asked questions

What is an opportunistic infection?

An infection caused by an organism that rarely causes disease in people with intact immunity but can cause serious illness when host defences are impaired. Such infections are a hallmark of immunocompromised hosts.

Why are immunocompromised people treated as a special population?

Because impaired immunity raises their susceptibility, broadens the range of organisms that can cause disease, and can alter how infections present, they require distinct epidemiological and preventive considerations, such as tailored vaccination guidance.